CVE-2023-42435

low-risk
Published 2023-10-19

The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to perform actions with the permissions of a victim user.

Do I need to act?

-
0.10% chance of exploitation
EPSS score — low exploit probability
-
Not on CISA KEV list
No confirmed active exploitation reported to CISA
?
Patch status unknown
Check vendor advisories for fix availability and mitigation guidance
5
CVSS 5.5/10 Medium
NETWORK / LOW complexity

Affected Products (1)

Dexgate

Affected Vendors

Dexma

References (2)

Third Party Advisory https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02
Third Party Advisory https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02
26
/ 100
low-risk
Severity 21/34 · High
Exploitability 0/34 · Minimal
Exposure 5/34 · Minimal